Dieter Gericke

Dieter Gericke heads the Corporate / M&A team. He focuses on public and private mergers & acquisitions, private equity, capital markets (incl. IPOs) and finance. He advises in matters of corporate law and securities regulations. Dieter Gericke also heads the Homburger China Group and co-heads the Healthcare / Life Sciences Group.

• Advising CSL in the public take-over of Vifor Pharma
• Advising ChemChina in the public takeover of Syngenta
• Advising EF in the sale of its China kids business
• Advising Therachon in the sale to Pfizer
• Advising Meyer Burger in a proxy fight and capital increase

• Capital markets: Equity
• M&A
• Private equity
• Restructuring and insolvency

• Financial services
• Food and beverage
• Industrials
• Pharma and life sciences
• Tech and telecoms

• At all Swiss courts

• Zurich Bar Association
• International Bar Association (Corporate and M&A Law Committee, Securities Law Committee)

• lic. iur., University of Zurich, (1991)
• Dr. iur., University of Zurich, (1996)
• LL.M., Harvard Law School, (1999)